Loading...
My Patient Taking A Novel Oral Anticoagulant Needs Surgery, Device Implantation, Or Ablation
Atrial fibrillation (AF) is a highly prevalent chronic condition and a growing number of patients are on chronic anticoagulation therapy with novel oral anticoagulant (NOAC) agents: dabigatran, rivaroxaban, and apixaban. Many of these patients are expected to require invasive procedures. There is no...
Na minha lista:
| Udgivet i: | J Atr Fibrillation |
|---|---|
| Main Authors: | , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Cardiofront, Inc
2014
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4956294/ https://ncbi.nlm.nih.gov/pubmed/27957125 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4022/jafib.1145 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|